Exercise of the over-allotment option in the IPO of Capio and end of stabilisation period
The Joint Global Coordinators, J.P. Morgan and SEB, have today notified Capio AB (publ) (“Capio”) and Ygeia Equity AB [1] (“Ygeia”) that the over-allotment option has been exercised in full in respect of 4,812,261 shares in Capio and that the stabilisation period has ended.
In connection with the initial public offering of Capio, Ygeia granted the banks an over-allotment option of up to 4,812,261 shares to be used to cover potential over-allotments of shares. During the stabilisation period, which commenced on June 30, 2015 and ended today, stabilisation has been carried out by SEB as stabilisation manager at the prices specified below. The banks have exercised the over-allotment option in full in respect of 4,812,261 shares.
Following the exercise of the over-allotment option, and taking into consideration the sale of 1,197,176 shares to certain members of Capio’s group management and board of directors on July 24, 2015, Ygeia will hold 84,608,473 shares in Capio, corresponding to approximately 59.9 percent of the total number of shares in Capio.
Stabilisation prices per day
June 30, 2015 | SEK 48.50 |
July 1, 2015 | SEK 48.50 |
July 3, 2015 | SEK 48.50 |
July 6, 2015 | SEK 48.50 |
For information, please contact:
Thomas Berglund, President and CEO of Capio
Phone: +46 73 388 8600
Email: thomas.berglund@capio.com
Henrik Brehmer, SVP Corporate Communications and Public Affairs
Phone: +46 76 111 3414
Email: henrik.brehmer@capio.com
[1] Ygeia Equity AB is owned by Nordic Capital Fund VI, the Apax Europe VI fund (advised by Apax Partners LLP) and the Apax France VII fund (managed by Apax Partners S.A)
[2] Pro forma net sales after adjustments MSEK 12,960
Capio is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services in four countries through its hospitals, specialist clinics and primary care units. In 2014, Capio’s 12,357 employees provided healthcare services during 4.6 million patient visits across the Group’s facilities in Sweden, Norway, France and Germany, generating net sales of MSEK 13,200[2]. Capio operates across three geographic segments: Nordic 54 percent of Group net sales, France 37 percent of Group net sales and Germany 9 percent of Group net sales. For more information about Capio, please see www.capio.com.
Tags: